NMDA receptors are glutamate-and glycine-gated channels that mediate fast excitatory transmission in the central nervous system and are critical to synaptic development, plasticity and integration. They have a rich complement of modulatory sites, which represent important pharmacologic targets. Ifenprodil is a well-tolerated NMDA receptor inhibitor; it is selective for GluN2B-containing receptors; and has neuroprotective effects. The mechanism by which ifenprodil inhibits NMDA receptor responses is not fully understood. The inhibition is incomplete and non-competitive with other known NMDA receptor agonists or modulators, although reciprocal effects have been reported between ifenprodil potency and that of extracellular ligands including glutamate, glycine, zinc, protons and polyamines. Recently, structural studies revealed that ifenprodil binds to a unique site at the interface between the extracellular N-termini of GluN1 and GluN2B subunits supporting the view that interactions with other extracellular modulators are indirect. In this study, we examined how ifenprodil affects the gating reaction of NMDA receptors in conditions designed to minimize actions by contemporaneous ligands. We found that ifenprodil decreased NMDA receptor equilibrium open probability by raising an energetic barrier to activation and also by biasing the receptor toward low open probability gating modes. These results demonstrate intrinsic effects of ifenprodil on NMDA receptor stationary gating kinetics and provide means to anticipate how ifenprodil will affect receptor responses in defined physiologic and pathologic circumstances.
Introduction
NMDA receptors are critical to fundamental properties of the central nervous system but also contribute to several debilitating brain pathologies and dysfunctions (Cull-Candy, 2007; Kalia et al., 2008) . Excessive activation of NMDA receptors has been implicated in excitotoxic neurodegeneration and NMDA receptor inhibitors hold promise as clinically useful therapeutics. Ifenprodil, a synthetic phenylethanolamine, is the lead compound within a series of subtype-specific inhibitors that exhibit >200-fold selectivity for GluN2B-containing NMDA receptors (2B) (Carron et al., 1971; Carter et al., 1988; Williams, 1993) . Ifenprodil's isoform specificity, high potency, and positive therapeutic index generated vivid interest in defining its mechanism of action at NMDA receptors.
High-affinity ifenprodil inhibition of NMDA receptor currents occurs in the nM range and is mediated through an extracellularly located binding site (Carter et al., 1988; Legendre & Westbrook, 1991) . This inhibition is incomplete; does not alter single-channel conductance; and causes channel openings to become shorter and less frequent (Reynolds & Miller, 1989; Legendre & Westbrook, 1991) . This evidence strongly supports an allosteric mechanism; however, whether ifenprodil has direct, intrinsic effects on channel gating or whether it acts indirectly by modifying the receptor's sensitivity to co-existing extracellular ligands remains to be determined. Ifenprodilbound NMDA receptors have ~5-fold higher apparent affinity for glutamate, are less sensitive to glycine, and are more sensitive to inhibition by omnipresent cations such as proton and zinc (Ransom, 1991; Kew et al., 1996; Mott et al., 1998; Rachline et al., 2005) . Based on these observations, it was proposed that ifenprodil may lower channel open probability by reducing glycine potency (Williams, 1993) ; by increasing the occupancy of agonist-bound desensitized states (Kew et al., 1996) ; and by enhancing tonic inhibition by ambient protons (Mott et al., 1998) .
NMDA receptors are obligate heterotetramers of two glycine-binding GluN1 subunits and two glutamate-binding GluN2 subunits. Four GluN2 subunits (A-D) have tightly regulated expression in vivo and determine the receptor's pharmacology and kinetics.
The extracellular portion of each subunit consists of two structural modules: an Nterminal domain (NTD) and a ligand-binding domain (LBD) , which in tetrameric This article has not been copyedited and formatted. The final version may differ from this version.
Molecular Pharmacology Fast Forward. Published on August 30, 2012 as DOI: 10.1124 at ASPET Journals on November 7, 2016 molpharm.aspetjournals.org Downloaded from receptors arrange as stacked dimers of heterodimers (Sobolevsky et al., 2009; Karakas et al., 2011; Lee & Gouaux, 2011) . Structural data established in atomic detail that glycine and glutamate bind within the LBD clefts of GluN1 and GluN2 subunits, respectively (Furukawa & Gouaux, 2003; Furukawa et al., 2005; Inanobe et al., 2005) ; zinc binds within the NTD clefts of GluN2 subunits (Karakas et al., 2009) ; and ifenprodil binds to residues located deep within the dimer interface formed by GluN1 and GluN2
NTDs (Karakas et al., 2011) . Residues responsible for proton inhibition have not been identified with certainty but are most likely located within the NTD of GluN1 subunits Huggins & Grant, 2005) . The merged structural view shows unequivocally that these modulatory sites are discrete and that they reside at considerable distance from each other; however, the picture of how they influence receptor gating and each other's actions is still incomplete.
Ample functional evidence demonstrates reciprocal influences between perturbations in the NTD and LBD layers and has consolidated the view that NTD ligands represent allosteric modulators with high therapeutic potential. Further, as mathematical descriptions of single-molecule behaviors have continued to improve, detailed kinetic mechanisms for these inhibitory actions have been delineated Amico-Ruvio et al., 2011) . Essentially, the activation of 2B receptors consists of rapid agonist binding, slow channel gating, even slower channel desensitization, and occasional gating-mode changes. Single-channel measurements showed that after binding glutamate and before populating open states, (glycine-bound) receptors transition through at least three kinetically resolvable pre-open states; occasionally, receptors escape this active gating cycle by entering desensitized states; and on a minutes time-scale they can also change gating mode (Banke & Traynelis, 2003; Amico-Ruvio & Popescu, 2010) . With this model in mind, allosteric ligands may inhibit NMDA receptors by causing pre-open or desensitized events to become longer; open events to become shorter; low-activity gating modes to become more prevalent; or any combination of the above mechanisms. Importantly, each of these mechanisms results in distinct kinetic signatures, which ultimately define how the modulator impacts biological function (Popescu, 2005; Popescu et al., 2010) .
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6 To delineate how ifenprodil affects the gating mechanism of NMDA receptors, we examined single-channel currents produced by 2B-containing NMDA receptors in the presence of ifenprodil and in conditions that minimized confounding effects by ambient extracellular ligands. Based on these results, we conclude that ifenprodil-binding causes channel closures to become longer, and thus openings to become less frequent by increasing an energetic barrier to channel activation; it also causes openings to become on average shorter by favoring low open probability gating modes. These results reveal an intrinsic effect of ifenprodil on channel gating, and represent an important element in anticipating how ifenprodil affects NMDA receptor responses in in situ.
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Materials and Methods:
All methods were similar to those described in detail previously (Kussius et al., 2009; Amico-Ruvio & Popescu, 2010) . Briefly, rat GluN1-1a (NR1-1a, U08261) and GluN2B (NR2B, NM012574) clones were expressed from pcDNA3.1(+) in HEK293 cells together with GFP.
Whole-cell currents were recorded with intracellular solutions containing (in mM): 135 CsF, 33 CsOH, 2 MgCl 2 , 1 CaCl 2 , 10 HEPES and 11 EGTA, pH 7.4 (CsOH) and clamped at -70 mV. Clamped cells were perfused with extracellular solutions containing (in mM): 150 NaCl, 2.5 KCl, 0.5 CaCl 2 , 10 HEPBS, 0.01 EDTA, and 0.1 glycine, with 1 mM glutamate and 150 nM ifenprodil added as specified. Currents were amplified and low-pass filtered at 2 kHz (Axopatch 200B; 4-pole Bessel), sampled at 5 kHz (Digidata, 1322A) and written into digital files with pClamp 10 (Molecular Devices, Sunnyvale, CA).
Analyses were done with OriginPro 8.0 software.
Excised patch currents were recorded with pipette (intracellular) solutions containing (in mM): 135 CsF, 33 CsOH, 2 MgCl2, 1 CaCl2, 10 HEPES and 11 EGTA, adjusted to pH 7.4 (CsOH) and clamped at -100 mV. Upon reaching the outside-out configuration the patch was perfused with (extracellular) solutions containing (mM): 150 NaCl, 2.5 KCl, 0.5 CaCl2, 0.1glycine, 0.01 EDTA, 10 HEPBS adjusted to pH 8.0. Glutamate 1 mM and/or ifenprodil 150 nM were added as indicated. Two extracellular solutions were applied simultaneously through a glass theta tube (2.0 mm diameter, Harvard Apparatus). A lightly pressurized perfusion system maintained the flow rate at 200 µl min -1 and helped to form a sharp interface between the two streams. The recording pipette containing the excised membrane patch was positioned within one stream close to the interface, and the theta tube mounted on a piezoelectric translator (Burleigh LSS-3100/3200) was used to exchange solution around the patch pipette. Open-tip potential measurements done at the end of each experiment showed that the 10 -90% exchange occurred within 0.15 -0.25 ms (Amico-Ruvio et al., 2011) . Each barrel of the theta tube was connected to several solutions through a micro manifold controlled with pinch valves (VC 6, Warner Instruments). Recorded currents were low-pass filtered at 5 kHz Single-channel currents were recorded from cell-attached patches with glass electrodes filled with extracellular solution containing (in mM): 150 NaCl, 2.5 KCl, 1 EDTA, 10 HEPBS, 1 glutamate and 0.1 glycine, adjusted to pH 8 (NaOH). Channel openings were recorded as sodium influxes after applying +100 mV through the recording pipette.
Currents were amplified and low-pass filtered at 10 kHz (Axopatch 200B; 4-pole Bessel), sampled at 20 kHz (PCI-6229, M Series card, National Instruments, Austin, TX) and written into digital files with QuB acquisition software (www.qub.buffalo.edu, University at Buffalo, Buffalo, NY).
Processing and analyses were done on records selected to have only one active channel and which required minimum processing, as described in detail previously (Kussius et al., 2009) . Idealization (SKM) and modeling (MIL) were done in QuB using 12 kHz digitally filtered data, onto which we subsequently imposed a 0.15 ms resolution. Simulations of ensemble responses to square jumps into 1 mM glutamate were simulated as the sum of time-dependent open state occupancies and were analyzed in a manner similar to experimental macroscopic traces (Popescu et al., 2004) . We used previously reported microscopic rates for glutamate binding and dissociation: k + = 6x10 6 M -1 s -1 and k -=15 s -1 , respectively (Amico-Ruvio & Popescu, 2010) . 
Results

Single-channel kinetics of ifenprodil-bound 2B receptors
Ifenprodil concentrations reduce NMDA receptor responses in a biphasic manner and the high-affinity component is specific to 2B containing NMDAR receptors (Carter et al., 1988; Reynolds & Miller, 1989; Legendre & Westbrook, 1991) . At physiologic pH, the reported half-maximal inhibition for this high-affinity component is in the 130 -340 nM range (Williams, 1993; Kew et al., 1996; Pahk & Williams, 1997; Mott et al., 1998; Perin-Dureau et al., 2002) . We focused on the mechanism of high-affinity inhibition by recording single-channel activity from one-channel cell-attached patches of HEK293 cells transiently transfected with GluN1-1a and GluN2B subunits in the presence of 150 nM ifenprodil (IFN) (Figure 1A) . To limit the effects of contemporaneous extracellular ligands, we recorded single-channel activity in the presence of maximally effective concentrations of glutamate and glycine (1 mM and 0.1 mM, respectively; each >100fold EC 50 ); we included a strong metal chelator in the recording pipette to remove trace divalent cations (1 mM EDTA); and we clamped proton concentrations at 10 nM (pH 8)
with a buffer that is highly effective in this concentration range (10 mM HEPBS, pKa = 8.3). As controls, we used a set of recordings obtained in identical conditions and the absence of ifenprodil (CTR) (Figure 1B ) (Amico-Ruvio & Popescu, 2010) . Both data sets included only records that originated from a single active channel, and we processed and analyzed all records in an identical manner (Kussius et al., 2009; Amico-Ruvio & Popescu, 2010) .
We found that ifenprodil decreased the average equilibrium open probability (P o ) of 2B receptors ~4-fold with no change in the single-channel amplitude (p > 0.05) ( Table 1) .
Thus, the ifenprodil concentration selected (150 nM) was sufficient to produce a substantial effect on channel gating and had no effect on single-channel conductance.
Further, we were able to attribute the decrease in P o to a ~2-fold increase in the mean duration of closures (MCT), and a ~1.6-fold decrease in mean duration of openings (MOT) ( Table 1) . These results are consistent with previous reports of ifenprodil effects on single channel activity of neuronal NMDA receptors (Legendre & Westbrook, 1991) .
Next, we examined in closer detail the mechanism by which these gating effects arose.
Ifenprodil-bound receptors had longer closures and more short openings
The NMDA receptor gating mechanism of 2B receptors although complex has been well characterized (Banke & Traynelis, 2003; Erreger et al., 2005; Amico-Ruvio & Popescu, 2010 All the one-channel records we obtained with IFN (n = 6) were well described with five closed components (E 1 -E 5 ), as we had reported previously for CTR (n = 31) ( Figure   2A ) (Amico-Ruvio & Popescu, 2010) . This result indicates that ifenprodil binding did not produce additional closed conformations, instead it altered specific closed components: E 2 , E 3 and E 4 , were ~3-fold longer and the area corresponding to the E 2 component increased 1.6-fold (from 19 ± 2% to 31 ± 3 %, p < 0.05), at the expense of a 3-fold decrease in the E 1 component area (from 20 ± 2 to 6.8 ± 0.4 %, p< 0.05) ( Figure 2B) .
Importantly, ifenprodil did not change the time constant of the longest closed component (E 5 ), which encompasses the longest desensitized events. Together with the observation that ifenprodil did not alter channel conductance, these results strongly exclude contributions by channel block and longer dwells in desensitized conformations as elements of the inhibitory mechanism of ifenprodil.
A similar analysis of open periods is more difficult to carry out and to interpret because of the heterogeneity introduced by modal behavior (Popescu, 2012) . In practice, Based on this observation, we reasoned that the shorter MOT observed in the ifenprodil-treated set must reflect a larger proportion of modes with shorter openings ( Table 2) . This inference was supported by significantly smaller areas observed in the IFN data set for the medium and high components (a med and a high ) ( Figure 3B) . To test whether this result may have been skewed by the substantially fewer records we obtained with ifenprodil relative to CTR, we selected from each set those records that
displayed all four open components (CTR, n = 6 and IFN, n = 3). Similar to our results obtained for the complete data sets, the ifenprodil-treated group had significantly shorter MOT (1.4-fold, p < 0.006); had essentially unchanged time constants for the four open components (p > 0.05); and had considerably higher proportion of short components (a fast and a low ) ( Table 2) . Based on these analyses, we conclude that ifenprodil-bound receptors had shorter openings on average because they spent more time in the lowactivity gating mode; however, medium-and high-activity modes were still accessible and during these periods, openings were of similar duration to those of ifenprodil-free receptors. This inhibitory mechanism was unexpected because it was not observed with zinc, which is also an NTD ligand (Amico-Ruvio et al., 2011) . 
Kinetic models of ifenprodil actions on 2B receptors
Next, we summarized these kinetic changes using a 5C1O kinetic scheme, which although clearly a simplification of the complex rearrangements that occur during NMDA receptor gating, captures the salient features of its microscopic and macroscopic behaviors (Popescu et al., 2004; Kussius et al., 2009) . Because, in this study, we used high concentrations of glutamate and glycine (1 mM and 0.1 mM, respectively, which are >100-fold EC 50 ) the agonist dissociation events were briefer than the time resolution used in our analyses, and thus, we were safe to assume that all events recorded reflected dwells in agonist-bound receptor states. Despite these simplifying assumptions, the kinetic modeling analysis provided important mechanistic insight as presented below.
Given that our stationary recordings were done using only half of the maximally effective IFN concentration (150 nM), we expected that in our IFN data set each record contained events corresponding to dwells in IFN-free as well as in IFN-bound states. This condition can be conceptualized with two types of models. Fitting the data by a 5C1O model, which represents the average behavior of IFN-bound and IFN-free receptor at the concentration used, identifies IFN-dependent transitions and provides insight into mechanism. Fitting the data by a tiered model, in which each arm represents IFN-free and IFN-bound gating reactions, can provide insight into ifenprodil binding kinetics and mechanism.
According to the average 5C1O model, 150 nM ifenprodil changed only a subset of the ten rate constants considered: k 3 2 , k 2 3 , k 4 2 and k 1 O (Figure 4A) . Each of these four rate constants decreased to a similar extent (3-to 4-fold), and resulted in significant changes in only two equilibria: K 2-4 (from 0.3 to 0.8) and K 1-O (from 4.6 to 1.6). Based on this mechanisms, the decrease in open state occupancy at equilibrium is compensated mainly by a ~2.5-fold increase in the occupancy of the desensitized state C 4 ( Figure   4B ). We next used the deduced CTR and IFN reaction mechanisms to calculate the relative free-energy fluctuations during gating, and we illustrate these in Figure 4C . To compare the two profiles, we arbitrarily aligned these at the free-energy level of the first fully liganded closed state C 3 . According to this interpretation, ifenprodil decreased Figure 4A, CTR) ; in the IFN-bound arm, the rate constants that were found invariant in the IFN data set relative to the CTR data set were fixed to IFN values (Figure 4A, IFN: k 2 1 , k 1 2 , k 2 4 , k 3 5 , k 5 3 ); all other rate constants in the IFN-bound arm were allowed to vary during fitting: k 3 2 , k 2 3 , k 4 2 , k 1 O , and k O 1 . Initially, we connected the two arms with ifenprodil association/dissociation transitions and allowed these to vary during fitting but this model failed to represent the IFN data set, even when binding and dissociation rates were constrained to be equal regardless of the position in the model.
Next, we considered models where ifenprodil binding/dissociation transitions were allowed only between a subset of gating steps. Consistently, the model represented in Figure 5 returned best fitting scores using a log likelihood criterion. This is an interesting result because it implies that transitions between IFN-free and IFN-bound states occur with highest probability when the receptor resides in the closed state C 3 .
Given that the C 3 state represents a collection of closed receptor conformations, which at a minimum includes brief agonist-free states, agonist-bound states with open and closed agonist-binding clefts, as well as agonist bound states that differ in the relative position of the ligand binding domains, this analysis may indicate that ifenprodil binds to NMDA receptors before or immediately after glutamate-binding. However, the implication of state-dependent binding requires more detailed investigation. Importantly, the tiered model estimated values for the ifenprodil association and dissociation rate constants: k on = 1.4 x 10 9 M -1 sec -1 and k off = 90 s -1 (K d = 64 nM). The association rate constant estimated here is 20-fold faster than that previously estimated as a blocking rate constant in hippocampal neurons (6 x 10 7 M -1 sec -1 ) (Legendre & Westbrook, 1991) , and the estimated K d is 5-fold lower than that determined from calorimetric measurements for a mixture of soluble N-terminal domains detached from N1 and N2B subunits (K d = 320 nM) (Karakas et al., 2011) . However, our K d matches closely the IC 50 determined in Xenopus oocytes with the two-electrode voltage clamp method (IC 50 = 100 nM) (Karakas et al., 2011) .
Experimental validation for the proposed mechanism of ifenprodil action
The models illustrated in Figure 4A postulate a mechanism for ifenprodil inhibition in which a shift in the equilibrium distribution of 2B receptors away from open states is compensated by a ~2.5-fold increase in the occupancy of the desensitized state C 4 ( Figure 4C) . However, because the C 4 state is only scarcely populated (~5% in the absence of ifenprodil), the model predicts that this change will not visibly affect the time course of macroscopic desensitization, as illustrated by simulations with CTR and IFN models (Figure 6A) . We tested this prediction by recording whole-cell currents following long (5 s) applications of glutamate (1 mM) while glycine was continuously present (0.1 mM). Results showed that indeed, relaxation to equilibrium occurred with a similar time course whether ifenprodil was present or not (n = 6 cells for each condition) ( Figure   6A ). In addition, we observed that the inhibition produced by 150 nM ifenprodil was less pronounced for whole-cell current responses (~50%) than that observed for cellattached receptors (75%) (Figure 6A, Table 1 ). This may reflect a higher incidence of receptors already gating in low activity mode in this preparation.
Further, we used the deduced models from Figure 4A to anticipate how ambient ifenprodil (150 nM) may affect synaptic NMDA receptor responses. Simulation results suggested that the major effect of ifenprodil will be a substantial decrease in charge transfer (~ 3.5-fold) due primarily to a comparable decrease in current amplitude and only small change in deactivation time course. To test this prediction, we recorded currents from 2B receptors residing in excised outside-out patches and exposed to brief (Figure 6B) . The close match between the kinetic behaviors of macroscopic traces predicted by our model, and that of responses recorded from wholecell and excised patch preparations represent a strong argument that the kinetic mechanism deduced from single-channel data captures the relevant features of the ifenprodil effects on 2B-containing NMDA receptors.
Discussion
In this report, we describe the effects of sub-saturating concentrations of ifenprodil on currents recorded from 2B NMDA receptors. We recorded on-cell single-molecule activity in the presence of maximally effective concentrations of agonists and in the virtual absence of extracellular modulators. Relative to controls, ifenprodil (150 nM) reduced channel P o by 75% largely because in its presence a set of channel closures were longer and because the fraction of short openings was larger. Within the context of a multi-step gating reaction, these observations were consistent with a mechanism in which ifenprodil-bound receptors gated according to the same sequence of activation, desensitization and mode switching transitions experienced by ifenprodil-free receptors, with only a subset of rate constants changed. The reduced activity could be explained by a mechanism where ifenprodil binding increased the energy barrier to activation and favored gating in low activity mode. In addition, the proposed mechanism estimates association and dissociation rate constants for ifenprodil.
This mechanism predicted that macroscopic responses elicited by glutamate in the presence of ifenprodil would have lower peak amplitudes; will have similar deactivation and desensitization profiles; and the degree of inhibition will be greater for preparations containing receptors that gate preferentially in high and/or medium modes. We were able to gather preliminary experimental support for these predictions. We recorded macroscopic responses to long (5 s) and brief (10 ms) applications of glutamate (1 mM) and observed that indeed, responses recorded when ifenprodil was present had lower amplitudes but largely similar deactivation and desensitization time courses relative to same-cell controls. These results strongly indicate that our model incorporates the salient features of the ifenprodil inhibitory mechanism. In a previous study we showed that the biphasic nature of NMDA receptor deactivation reflects two NMDA receptor populations gating in distinct modes (Zhang et al., 2008) . Thus, a modulator capable of altering receptor distribution across modes will certainly influence deactivation kinetics and the time course of synaptic currents. However, due to the low incidence of modal changes in our stationary recordings, we were not able to model neither kinetics within specific modes nor the kinetics of mode switching; thus, here we only examined the overall profile of the current decay. Still, both the simulated and the recorded responses clearly showed that ifenprodil changed the time course of 2B receptor deactivation;
however, these changes were much smaller than the dramatic decrease in current amplitude, and, thus, the major effect on the magnitude of charge transfer was accounted for by changes in current amplitude.
The degree of inhibition for whole-cell currents (50%) was lower than for excised-patch currents, and also lower than predicted from cell-attached measurements (75%). This decrease in inhibitory effect for preparations where the integrity of the cellular membrane is compromised (whole-cell and excised patch) may reflect an increase prevalence in these conditions of low activity modes, which are inhibited to a lesser degree than high activity modes. Legendre and Westbrook (1991) also noted that ifenprodil inhibition was less pronounced for whole-cell than for excised-patch currents, and that whole-cell current inhibition is further attenuated after channels undergo calcium-dependent inactivation (Legendre & Westbrook, 1991) . However, our experiments did not address these issues.
The uncertainty of mode switching notwithstanding, our results demonstrate that ifenprodil re-shuffled receptors across the spectrum of available conformations. As and zinc and interferes with polyamine potentiation (Reynolds & Miller, 1989; Ransom, 1991; Mott et al., 1998; Rachline et al., 2005) . In addition, ifenprodil affects the potency of LBD ligands glycine, glutamate, and NMDA (Ransom, 1991; Kew et al., 1996; Mott et al., 1998) . For these reasons, it has been proposed that rather than having an intrinsic
action on receptor open probability, ifenprodil acts by enhancing the inhibitory potency of coincident ligands, and/or causes agonists to become less effective (Ransom, 1991; Mott et al., 1998) .
We proposed previously that allosteric modulators, those ligands that cause a redistribution of NMDA receptors across accessible states, in conjunction to changing P o can also change other receptor functionalities such as their apparent sensitivity to coincident ligands (Popescu, 2005) . Such a combined effect would be observed if a given modulator changed the proportion of open states and also the proportion of states that have distinct affinities for separate ligands, whether these have distinct conductances or not. The results presented here show that 150 nM ifenprodil caused ~75% inhibition of 2B receptor currents even when receptors were fully-bound with glutamate and glycine, in the absence of trace amounts of Ca 2+ and Zn 2+ , and with protons at 10-fold lower than the half-effective inhibitory dose (Traynelis & Cull-Candy, 1990Traynelis & Cull-Candy, 1990 Mott et al., 1998; Banke et al., 2005) . Thus, our results support a mechanism where ifenprodil binding has intrinsic consequences on channel gating, which by means of changing the proportion of states with high-and lowaffinity for secondary ligands, can also change the receptor's sensitivity to these ligands.
Structural and functional evidence have consolidated the view that although separate, the molecular determinants of proton, zinc and ifenprodil inhibition are located within the N-terminal layer. Our results indicate that the mechanism of ifenprodil inhibition is distinct from that of protons or zinc, the two NTD ligands for which kinetic models have been proposed to date. Therefore, our new observations substantiate the view that perturbations in the NTD, rather than deploying a common inhibitory mechanism, exert specific actions, which may be exploited for separate clinical purposes. In summary, our results add to the already ample evidence that NMDA receptors are highly allosteric molecules and provide mechanistic support for the hypothesis that the sum result of NMDA receptor activation is highly dependent on the composition of their extra-and intracellular environments. Keeping in mind that ifenprodil is investigated as a potential therapeutic agent for a number of NMDA receptor mediated pathologies and is also widely used as a research tool, it will be important to consider its action in context with co-existing factors. As quantitative descriptions of allosteric perturbations, either chemical or genetic, become available it will be possible to predict receptor behaviors in highly customized environments. Our report represents one necessary element toward the greater goal of anticipating receptor drug effects in specific conditions, thus, forecasting with greater confidence and accuracy potential outcomes.
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